Week20, 2023
1. Influenza activity remains low nationally; 1.1% of clinical specimens tested positive for influenza this week, stable from the previous week.
2. Public health labs reported 36 positive specimens, with 36.1% Influenza A (all A(H1N1)pdm09) and 63.9% Influenza B (Victoria lineage).
3. Outpatient visits for influenza-like illness (ILI) accounted for 2.0%, below the national baseline of 2.5%, with stable trends across age groups and regions.
4. Hospitalizations this week were 939, contributing to a cumulative rate of 62.6 per 100,000, with the highest rates in adults aged 65+ and children aged 0-4 years.
5. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) accounted for 6.5%, slightly above the epidemic threshold; 15 deaths were influenza-associated.
6. Two influenza-associated pediatric deaths were reported this week for a total of 154 this season.
7. Influenza A accounted for 98% of infections this season, with A(H3N2) dominating overall, while B comprised only 2% of total cases (mostly Victoria lineage).
8. CDC reported all tested viruses were susceptible to antiviral medications, except one A(H1N1)pdm09 virus with reduced inhibition to oseltamivir.
9. CDC recommends annual flu vaccination; this seasonâ€™s vaccine is reported to be antigenically similar to circulating strains, with no new vaccination trends highlighted.
10. Co-circulation of multiple respiratory pathogens, including SARS-CoV-2, impacts respiratory illness patterns, with 3.7% of flu-associated hospitalizations also positive for COVID-19.